Calithera is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small molecule therapies that disrupt cellular metabolic pathways to preferentially block tumor cell growth and enhance immune-cell activity. Tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. They offer the potential for fundamentally new therapies for people with ca...
Calithera is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small molecule therapies that disrupt cellular metabolic pathways to preferentially block tumor cell growth and enhance immune-cell activity. Tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. They offer the potential for fundamentally new therapies for people with cancer and other life-threatening diseases.
Calithera’s pipeline consisting of multiple, novel compounds targets key metabolic enzymes to disrupt metabolic pathways that provide tumor and other diseased cells.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.